Expert consensus statement for periprocedural anticoagulation and antiplatelet therapy in elective bronchoscopy

The aim of these guidelines is to minimize the risk of bleeding and thromboembolic complications in the periprocedural period of an endoscopic procedure. It is therefore reasonable to divide patients into groups at low, moderate, and high risk of thromboembolism (TE) (Table 1), and endoscopic procedures into groups carrying a low or high bleeding risk (Table 3). Generally, as the risk of TE increases, it is critical to minimize or discontinue anticoagulation therapy for a period as short as possible. On the other hand, with increasing risk of procedure-related bleeding, it is critical to extend the period a r t i c l e i n f o